Click here to subscribe to our newsletter |
|
![](http://www.worldpharmatoday.com/images/article/Weekly_newsletter/comman_images/6.png) |
Articles |
|
|
|
|
Pharma Cold Chain Logistics - There is more to it than meets the eye
Pharmaceuticals and logistics have seen unparallel growth in the modern world. Needless to say, they have evolved like none other over a period of time.
Their dependence on one another has become noteworthy of late with technology taking over in full swing.
|
|
|
| |
|
![](https://www.worldpharmatoday.com/wp-content/uploads/articles/9829/digital_pharma.jpg) |
Digital readiness of Pharma Industry |
Adopting varied lifestyles has become a new normal in today’s era. We are all aware of how lifestyle diseases have become so much prevalent these... |
|
![](https://www.worldpharmatoday.com/wp-content/uploads/articles/9752/Rising_demand_for_stability_studies.jpg) |
Rising demand for stability studies |
From complex and high-sensitive substances to vaccines and biotechnologically produced proteins, production of drug products requires
a high-level...
|
|
|
| |
|
![](https://www.worldconstructiontoday.com/images/e-newsletters/all/7.png) |
Trends |
|
|
|
|
The Ever Growing Pharma Software Market in India
Globally, the acceptance of software in the pharma sector is much more as compared to India but many front line manufacturers have understood the need of being ahead with the time and hence have adopted software practices which are second to none.
|
|
| |
|
![](https://www.worldconstructiontoday.com/images/e-newsletters/all/7.png) |
News |
|
|
|
|
GSK invests $120 million in biopharma plant as its oncology pipeline grows
Amidst a pipeline bulging with oncology bets, GlaxoSmithKline has invested $120 million in a new biologics plant. The announcement was made by Emma Walmsley, CEO, at the drugmaker...
|
|
|
| |
|
|
|
Mylan to invest $1 Billion in India on capex in 6 years
World Pharma Today / News / India - Mylan, a global generic and specialty Pharmaceuticals Company registered in the Netherlands has confirmed that...
|
|
| |
|
![](https://www.worldconstructiontoday.com/images/e-newsletters/all/7.png) |
Press Releases |
|
|
|
|
Aptar Pharma’s Nasal Unidose Device Approved for TosymraTM Sumatriptan Spray
Aptar Pharma announced that its patented Unidose Liquid System is the device which delivers TosymraTM (sumatriptan) Nasal Spray 10mg, for the acute treatment of migraine in adults.
|
|
|
| |
|
|
|
Novel silica delivery system Nuvec enters final pre-clinical development stage
N4 Pharma Plc , a specialist pharmaceutical company, has announced results fromthe company’s latest research study into its novel silica nanoparticle for cancer treatments and vaccines, Nuvec.
|
|
| |
|